palmitoylcarnitine and Ventricular Dysfunction

palmitoylcarnitine has been researched along with Ventricular Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belardinelli, L; Shryock, JC; Song, Y; Wu, Y	1

Other Studies

1 other study(ies) available for palmitoylcarnitine and Ventricular Dysfunction

Article	Year
The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 330, Issue:2 Topics: Acetanilides; Animals; Female; Guinea Pigs; Heart Failure, Diastolic; In Vitro Techniques; Male; Myocytes, Cardiac; Palmitoylcarnitine; Piperazines; Ranolazine; Sodium Channel Blockers; Sodium Channels; Ventricular Dysfunction	2009

Article

Year

The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.

The Journal of pharmacology and experimental therapeutics, 2009, Volume: 330, Issue:2

Topics: Acetanilides; Animals; Female; Guinea Pigs; Heart Failure, Diastolic; In Vitro Techniques; Male; Myocytes, Cardiac; Palmitoylcarnitine; Piperazines; Ranolazine; Sodium Channel Blockers; Sodium Channels; Ventricular Dysfunction

2009